DRKS00025567已完成不适用
Humoral immune response after COVID-19 vaccination. - HINCI-Bremen
Performa NordZentrum für Gesunde ArbeitArbeitsmedizinischer Dienst0 个研究点目标入组 103 人开始时间: 2021年6月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 103
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 68 Years（—）
- 性别
- All
入选标准
- •Condition after Corona vaccination. At least 2 weeks after the end of the vaccination series and not more than 3 months after the last vaccination.
排除标准
- •End of vaccination series not earlier than 14 days to not longer than 3 months ago.
研究者
相似试验
尚未招募
不适用
Humoral immune responses after receiving COVID-19 vaccination in cirrhotic patients.CirrhosisvaccinationCOVID-19cirrhosis, vaccination, COVID-19, CoronaVac, AstraZeneca, SARS-CoV-2 vaccine.TCTR20210622002Faculty of Medicine, Prince of Songla University100
尚未招募
不适用
COVID - antibody surveillance among Healthcare workersCTRI/2021/06/033967Institution MOSC Medical College Hospital Kolenchery Ernakulam
招募中
4 期
Antibody response to COVID-19 vaccination in immunosuppressed patients with autoimmune diseasePsoriatic arthritisAnkylosing spondylitisCOVID-19Inflammatory bowel diseaseInflammatory and Immune System - Autoimmune diseasesOral and Gastrointestinal - Crohn's diseaseOral and Gastrointestinal - Inflammatory bowel diseaseMusculoskeletal - Other muscular and skeletal disordersInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersInflammatory and Immune System - Rheumatoid arthritisCrohn's DiseaseRheumatoid arthritisUlcerative ColitisACTRN12621000661875Dr Ai Tran100
进行中（未招募）
1 期
Immune response to COVID-19 Vaccination in people with Diabetes MellitusType 1 Diabetes MellitusType 2 Diabetes MellitusEUCTR2021-001459-15-ATMedical University of Graz161
进行中（未招募）
1 期
COVID-19 vaccine induced immune response in patients with primary antibody deficiencyCOVID-19EUCTR2021-004891-33-FITurku University Hospital50